IBDEI08N ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11358,1,3,0)
 ;;=3^Deprivation Amblyopia
 ;;^UTILITY(U,$J,358.3,11358,1,4,0)
 ;;=4^368.02
 ;;^UTILITY(U,$J,358.3,11358,2)
 ;;=^265361
 ;;^UTILITY(U,$J,358.3,11359,0)
 ;;=368.11^^73^703^102
 ;;^UTILITY(U,$J,358.3,11359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11359,1,3,0)
 ;;=3^Sudden Visual Loss
 ;;^UTILITY(U,$J,358.3,11359,1,4,0)
 ;;=4^368.11
 ;;^UTILITY(U,$J,358.3,11359,2)
 ;;=^268831
 ;;^UTILITY(U,$J,358.3,11360,0)
 ;;=368.59^^73^703^11
 ;;^UTILITY(U,$J,358.3,11360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11360,1,3,0)
 ;;=3^Color Blindness
 ;;^UTILITY(U,$J,358.3,11360,1,4,0)
 ;;=4^368.59
 ;;^UTILITY(U,$J,358.3,11360,2)
 ;;=^87408
 ;;^UTILITY(U,$J,358.3,11361,0)
 ;;=368.60^^73^703^67
 ;;^UTILITY(U,$J,358.3,11361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11361,1,3,0)
 ;;=3^Night Blindness
 ;;^UTILITY(U,$J,358.3,11361,1,4,0)
 ;;=4^368.60
 ;;^UTILITY(U,$J,358.3,11361,2)
 ;;=^83350
 ;;^UTILITY(U,$J,358.3,11362,0)
 ;;=368.9^^73^703^113
 ;;^UTILITY(U,$J,358.3,11362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11362,1,3,0)
 ;;=3^Visual Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,11362,1,4,0)
 ;;=4^368.9
 ;;^UTILITY(U,$J,358.3,11362,2)
 ;;=^124001
 ;;^UTILITY(U,$J,358.3,11363,0)
 ;;=369.00^^73^703^108
 ;;^UTILITY(U,$J,358.3,11363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11363,1,3,0)
 ;;=3^Total Blindness,Both Eyes
 ;;^UTILITY(U,$J,358.3,11363,1,4,0)
 ;;=4^369.00
 ;;^UTILITY(U,$J,358.3,11363,2)
 ;;=^15310
 ;;^UTILITY(U,$J,358.3,11364,0)
 ;;=369.01^^73^703^109
 ;;^UTILITY(U,$J,358.3,11364,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11364,1,3,0)
 ;;=3^Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,11364,1,4,0)
 ;;=4^369.01
 ;;^UTILITY(U,$J,358.3,11364,2)
 ;;=^268861
 ;;^UTILITY(U,$J,358.3,11365,0)
 ;;=369.02^^73^703^75
 ;;^UTILITY(U,$J,358.3,11365,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11365,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye-NOS
 ;;^UTILITY(U,$J,358.3,11365,1,4,0)
 ;;=4^369.02
 ;;^UTILITY(U,$J,358.3,11365,2)
 ;;=^268862
 ;;^UTILITY(U,$J,358.3,11366,0)
 ;;=369.03^^73^703^74
 ;;^UTILITY(U,$J,358.3,11366,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11366,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye Total
 ;;^UTILITY(U,$J,358.3,11366,1,4,0)
 ;;=4^369.03
 ;;^UTILITY(U,$J,358.3,11366,2)
 ;;=^268863
 ;;^UTILITY(U,$J,358.3,11367,0)
 ;;=369.04^^73^703^64
 ;;^UTILITY(U,$J,358.3,11367,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11367,1,3,0)
 ;;=3^Near Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,11367,1,4,0)
 ;;=4^369.04
 ;;^UTILITY(U,$J,358.3,11367,2)
 ;;=^268864
 ;;^UTILITY(U,$J,358.3,11368,0)
 ;;=369.06^^73^703^77
 ;;^UTILITY(U,$J,358.3,11368,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11368,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,11368,1,4,0)
 ;;=4^369.06
 ;;^UTILITY(U,$J,358.3,11368,2)
 ;;=^268866
 ;;^UTILITY(U,$J,358.3,11369,0)
 ;;=369.07^^73^703^76
 ;;^UTILITY(U,$J,358.3,11369,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11369,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Near
 ;;^UTILITY(U,$J,358.3,11369,1,4,0)
 ;;=4^369.07
 ;;^UTILITY(U,$J,358.3,11369,2)
 ;;=^268867
 ;;^UTILITY(U,$J,358.3,11370,0)
 ;;=369.08^^73^703^91
 ;;^UTILITY(U,$J,358.3,11370,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11370,1,3,0)
 ;;=3^Profound Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,11370,1,4,0)
 ;;=4^369.08
 ;;^UTILITY(U,$J,358.3,11370,2)
 ;;=^268868
 ;;^UTILITY(U,$J,358.3,11371,0)
 ;;=369.10^^73^703^73
 ;;^UTILITY(U,$J,358.3,11371,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11371,1,3,0)
 ;;=3^One Eye-Blind,Oth-Low Vision
 ;;^UTILITY(U,$J,358.3,11371,1,4,0)
 ;;=4^369.10
 ;;^UTILITY(U,$J,358.3,11371,2)
 ;;=^268870
 ;;^UTILITY(U,$J,358.3,11372,0)
 ;;=369.11^^73^703^78
 ;;^UTILITY(U,$J,358.3,11372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11372,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Blind
 ;;^UTILITY(U,$J,358.3,11372,1,4,0)
 ;;=4^369.11
 ;;^UTILITY(U,$J,358.3,11372,2)
 ;;=^268871
 ;;^UTILITY(U,$J,358.3,11373,0)
 ;;=369.12^^73^703^81
 ;;^UTILITY(U,$J,358.3,11373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11373,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,11373,1,4,0)
 ;;=4^369.12
 ;;^UTILITY(U,$J,358.3,11373,2)
 ;;=^268872
 ;;^UTILITY(U,$J,358.3,11374,0)
 ;;=369.13^^73^703^79
 ;;^UTILITY(U,$J,358.3,11374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11374,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Near Total
 ;;^UTILITY(U,$J,358.3,11374,1,4,0)
 ;;=4^369.13
 ;;^UTILITY(U,$J,358.3,11374,2)
 ;;=^268873
 ;;^UTILITY(U,$J,358.3,11375,0)
 ;;=369.14^^73^703^80
 ;;^UTILITY(U,$J,358.3,11375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11375,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Profound
 ;;^UTILITY(U,$J,358.3,11375,1,4,0)
 ;;=4^369.14
 ;;^UTILITY(U,$J,358.3,11375,2)
 ;;=^268874
 ;;^UTILITY(U,$J,358.3,11376,0)
 ;;=369.22^^73^703^101
 ;;^UTILITY(U,$J,358.3,11376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11376,1,3,0)
 ;;=3^Severe Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,11376,1,4,0)
 ;;=4^369.22
 ;;^UTILITY(U,$J,358.3,11376,2)
 ;;=^268882
 ;;^UTILITY(U,$J,358.3,11377,0)
 ;;=369.60^^73^703^6
 ;;^UTILITY(U,$J,358.3,11377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11377,1,3,0)
 ;;=3^Blindness,One Eye Only
 ;;^UTILITY(U,$J,358.3,11377,1,4,0)
 ;;=4^369.60
 ;;^UTILITY(U,$J,358.3,11377,2)
 ;;=^268880
 ;;^UTILITY(U,$J,358.3,11378,0)
 ;;=369.9^^73^703^114
 ;;^UTILITY(U,$J,358.3,11378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11378,1,3,0)
 ;;=3^Visual Loss NOS
 ;;^UTILITY(U,$J,358.3,11378,1,4,0)
 ;;=4^369.9
 ;;^UTILITY(U,$J,358.3,11378,2)
 ;;=^126769
 ;;^UTILITY(U,$J,358.3,11379,0)
 ;;=377.61^^73^703^20
 ;;^UTILITY(U,$J,358.3,11379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11379,1,3,0)
 ;;=3^D/O Pathways w/ Neoplasm
 ;;^UTILITY(U,$J,358.3,11379,1,4,0)
 ;;=4^377.61
 ;;^UTILITY(U,$J,358.3,11379,2)
 ;;=^269241
 ;;^UTILITY(U,$J,358.3,11380,0)
 ;;=379.02^^73^703^68
 ;;^UTILITY(U,$J,358.3,11380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11380,1,3,0)
 ;;=3^Nodular Episcleritis
 ;;^UTILITY(U,$J,358.3,11380,1,4,0)
 ;;=4^379.02
 ;;^UTILITY(U,$J,358.3,11380,2)
 ;;=^269285
 ;;^UTILITY(U,$J,358.3,11381,0)
 ;;=379.07^^73^703^89
 ;;^UTILITY(U,$J,358.3,11381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11381,1,3,0)
 ;;=3^Posterior Scleritis
 ;;^UTILITY(U,$J,358.3,11381,1,4,0)
 ;;=4^379.07
 ;;^UTILITY(U,$J,358.3,11381,2)
 ;;=^269295
 ;;^UTILITY(U,$J,358.3,11382,0)
 ;;=379.92^^73^703^105
 ;;^UTILITY(U,$J,358.3,11382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11382,1,3,0)
 ;;=3^Swelling/Mass of Eye
 ;;^UTILITY(U,$J,358.3,11382,1,4,0)
 ;;=4^379.92
 ;;^UTILITY(U,$J,358.3,11382,2)
 ;;=^269334
 ;;^UTILITY(U,$J,358.3,11383,0)
 ;;=379.93^^73^703^93
 ;;^UTILITY(U,$J,358.3,11383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11383,1,3,0)
 ;;=3^Redness/Discharge of Eye
 ;;^UTILITY(U,$J,358.3,11383,1,4,0)
 ;;=4^379.93
 ;;^UTILITY(U,$J,358.3,11383,2)
 ;;=^104154
 ;;^UTILITY(U,$J,358.3,11384,0)
 ;;=379.99^^73^703^85
 ;;^UTILITY(U,$J,358.3,11384,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11384,1,3,0)
 ;;=3^Oth Ill-Defined Eye D/O
 ;;^UTILITY(U,$J,358.3,11384,1,4,0)
 ;;=4^379.99
 ;;^UTILITY(U,$J,358.3,11384,2)
 ;;=^269335
 ;;^UTILITY(U,$J,358.3,11385,0)
 ;;=555.9^^73^703^94
 ;;^UTILITY(U,$J,358.3,11385,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11385,1,3,0)
 ;;=3^Regional Enteritis,Unspec
 ;;^UTILITY(U,$J,358.3,11385,1,4,0)
 ;;=4^555.9
 ;;^UTILITY(U,$J,358.3,11385,2)
 ;;=^29356
 ;;^UTILITY(U,$J,358.3,11386,0)
 ;;=696.1^^73^703^92
 ;;^UTILITY(U,$J,358.3,11386,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11386,1,3,0)
 ;;=3^Psoriasis
 ;;^UTILITY(U,$J,358.3,11386,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,11386,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,11387,0)
 ;;=709.2^^73^703^39
 ;;^UTILITY(U,$J,358.3,11387,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11387,1,3,0)
 ;;=3^Facial Scar
 ;;^UTILITY(U,$J,358.3,11387,1,4,0)
 ;;=4^709.2
 ;;^UTILITY(U,$J,358.3,11387,2)
 ;;=^108131
 ;;^UTILITY(U,$J,358.3,11388,0)
 ;;=710.0^^73^703^60
 ;;^UTILITY(U,$J,358.3,11388,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11388,1,3,0)
 ;;=3^Lupus,Systemic Erythmatosis
 ;;^UTILITY(U,$J,358.3,11388,1,4,0)
 ;;=4^710.0
 ;;^UTILITY(U,$J,358.3,11388,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,11389,0)
 ;;=710.9^^73^703^10
 ;;^UTILITY(U,$J,358.3,11389,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11389,1,3,0)
 ;;=3^Collagen Disease NOS
 ;;^UTILITY(U,$J,358.3,11389,1,4,0)
 ;;=4^710.9
 ;;^UTILITY(U,$J,358.3,11389,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,11390,0)
 ;;=714.0^^73^703^97
 ;;^UTILITY(U,$J,358.3,11390,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11390,1,3,0)
 ;;=3^Rheumatoid Arthritis
 ;;^UTILITY(U,$J,358.3,11390,1,4,0)
 ;;=4^714.0
 ;;^UTILITY(U,$J,358.3,11390,2)
 ;;=^10473
 ;;^UTILITY(U,$J,358.3,11391,0)
 ;;=714.30^^73^703^98
 ;;^UTILITY(U,$J,358.3,11391,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11391,1,3,0)
 ;;=3^Rheumatoid Arthritis,Juvenile
 ;;^UTILITY(U,$J,358.3,11391,1,4,0)
 ;;=4^714.30
 ;;^UTILITY(U,$J,358.3,11391,2)
 ;;=^24424
 ;;^UTILITY(U,$J,358.3,11392,0)
 ;;=744.89^^73^703^38
 ;;^UTILITY(U,$J,358.3,11392,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11392,1,3,0)
 ;;=3^Face/Neck Anom NEC,Congenital
 ;;^UTILITY(U,$J,358.3,11392,1,4,0)
 ;;=4^744.89
 ;;^UTILITY(U,$J,358.3,11392,2)
 ;;=^272875
 ;;^UTILITY(U,$J,358.3,11393,0)
 ;;=759.6^^73^703^115
 ;;^UTILITY(U,$J,358.3,11393,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11393,1,3,0)
 ;;=3^Von-Hippel Lindau Disease
 ;;^UTILITY(U,$J,358.3,11393,1,4,0)
 ;;=4^759.6
 ;;^UTILITY(U,$J,358.3,11393,2)
 ;;=^87431
 ;;^UTILITY(U,$J,358.3,11394,0)
 ;;=759.82^^73^703^62
 ;;^UTILITY(U,$J,358.3,11394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11394,1,3,0)
 ;;=3^Marfan Syndrome
 ;;^UTILITY(U,$J,358.3,11394,1,4,0)
 ;;=4^759.82
 ;;^UTILITY(U,$J,358.3,11394,2)
 ;;=^74034
 ;;^UTILITY(U,$J,358.3,11395,0)
 ;;=802.4^^73^703^36
 ;;^UTILITY(U,$J,358.3,11395,1,0)
 ;;=^358.31IA^4^2
